In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DEA Proposal To Schedule Kratom Stirs Wave Of Opposition

This article is powered by The Rose Sheet

Executive Summary

AHPA and the American Botanical Council are among the opponents of DEA's proposal to schedule the active materials in kratom while NPA supports it, saying kratom products and raw ingredients have not met "the strict standards products and new ingredients must adhere to in order to be marketed to the public."


Related Content

Ohio's Proposed Ban On Sales Marks Kratom Industry's Latest Battlefront
Kratom Industry GMPs Target Swaying FDA By Exceeding Agency Standards
Kratom Group Contests FDA's Opioid Finding, Requests Joint Meeting With NIDA
Salmonella In Kratom, Like Use Of The Herb, Exceeds FDA Expectations
Las Vegas Kratom Marketer Rolls Dice On FDA's Mandatory Recall Authority
Kratom Advocates Urge Industry Compliance, FDA And DEA Compassion
FDA Waves Stop Sign At Kratom Product Launch After Failed NDI Notification
FDA's Kratom Campaign Turns To Firms Destroying Inventory, Recalling Products
DEA Takes Comments On Kratom, But Keeps Eye On Scheduling
Kratom Import Alert Clarifies FDA Deems The Botanical An Unsafe NDI





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts